Fluids are the only known method of attenuating renal injury. Furthermore, whether for hydration, resuscitation or renal replacement therapy, fluid prescriptions must be tailored to the fluid and electrolyte, cardiovascular status and residual renal function of the patient. Different fluids have significantly different effects both on volume expansion as well as on the electrolyte and acid-base balance; while controversial, different fluids may even influence renal function differently. This systematic review focuses on fluids for prevention and management of acute kidney injury. We have reviewed the available evidence and have made recommendations for clinical practice and future studies.
WatersJ.H., GottliebA., SchoenwaldP., PopovichM.J., SprungJ., NelsonD.R.. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: an outcome study.Anesth Analg2001; 93: 817–22.
2.
O'MalleyC.M., FrumentoR.J., HardyM.A.. A randomized, double-blind comparison of lactated Ringer's solution and 0.9% NaCl during renal transplantation.Anesth Analg2005; 100: 1518–24.
3.
WilcoxC.S.. Regulation of renal blood flow by plasma chloride.J Clin Invest1983; 7: 726–35.
4.
WilliamsE.L., HildebrandK.L., McCormickS.A., BedelM.J.. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers.Anesth Analg1999; 88: 999–1003.
5.
EngstromM., SchottU., RomnerB., ReinstrupP.. Acidosis impairs the coagulation: A thromboelastographic study.J Trauma2006; 6: 624–28.
6.
StantonK., AlamH.B., RheeP., LlorenteO., KirkpatrickJ., KoustovaE.. Human polymorphonuclear cell death after exposure to resuscitation fluids in vitro: apoptosis versus necrosis.J Trauma2003; 54: 1065–76.
7.
OliveiraR.P., WeingartnerR., RibasE.O., MoraesR.S., FriedmanG.. Acute haemodynamic effects of a hypertonic saline/dextran solution in stable patients with severe sepsis.Intensive Care Med2002; 28: 1574–81.
CooperD.J., MylesP.S., McDermottF.T.. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial.JAMA2004; 291: 1350–57.
10.
BrueggerD., BauerA., RehmM.. Effect of hypertonic saline dextran on acid-base balance in patients undergoing surgery of abdominal aortic aneurysm.Crit Care Med2005; 33: 556–63.
11.
HuangP.P., StuckyF.S., DimickA.R., TreatR.C., BesseyP.Q., RueL.W.. Hypertonic sodium resuscitation is associated with renal failure and death.Ann Surg1995; 221: 543–54.
AldersonP., BunnF., LefebvreC.. Human albumin solution for resuscitation and volume expansion in critically ill patients.Cochrane Database Syst Rev2004: (4) CD001208.
BiesenbachG., ZazgornikJ., KaiserW.. Severe tubulopathy and kidney graft rupture after coadministration of mannitol and ciclosporin.Nephron1992; 62: 93–6.
17.
MertenG.J., BurgessW.P., GrayL.V.. Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial.JAMA2004; 291: 2328–34.
18.
BriguoriC., AiroldiF., D'AndreaD.. Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies.Circulation2007; 115: 1211–17.
19.
BetterO.S., RubinsteinI., ReisD.N.. Muscle crush compartment syndrome: fulminant local edema with threatening systemic effects.Kidney Int2003; 63: 1155–57.
20.
SlaterM.S., MullinsR.J.. Rhabdomyolysis and myoglobinuric renal failure in trauma and surgical patients: a review.J Am Coll Surg1998; 186: 693–716.
21.
KnottenbeltJ.D.. Traumatic rhabdomyolysis from severe beating - experience of volume diuresis in 200 patients.J Trauma1994; 37: 214–19.
22.
BetterO.S., SteinJ.H.. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis.N Engl J Med1990; 322: 825–29.
23.
BrownC.V., RheeP., ChanL., EvansK., DemetriadesD., VelmahosG.C.. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?J Trauma2004; 56: 1191–96.
24.
HomsiE., BarreiroM.F., OrlandoJ.M., HigaE.M.. Prophylaxis of acute renal failure in patients with rhabdomyolysis.Ren Fail1997; 19: 283–88.
25.
GirbesA.R.. Prevention of acute renal failure: role of vasoactive drugs, mannitol and diuretics.Int J Artif Organs2004; 27: 1049–53.
26.
MuellerC., BuerkleG., BuettnerH.J.. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty.Arch Intern Med2002; 162: 329–36.
27.
Ip-YamP.C., MurphyS., BainesM., FoxM.A., DesmondM.J., InnesP.A.. Renal function and proteinuria after cardiopulmonary bypass: the effects of temperature and mannitol.Anesth Analg1994; 78: 842–47.
GubernJ.M., SanchoJ.J., SimoJ., Sitges-SerraA.. A randomized trial on the effect of mannitol on postoperative renal function in patients with obstructive jaundice.Surgery1988; 103: 39–44.
30.
GubernJ.M., Martinez-RodenasF., Sitges-SerraA.. Use of mannitol as a measure to prevent postoperative renal failure in patients with obstructive jaundice.Am J Surg1990; 159: 444–45.
31.
van ValenbergP.L., HoitsmaA.J., TiggelerR.G., BerdenJ.H., van LierH.J., KoeneR.A.. Mannitol as an indispensable constituent of an intraoperative hydration protocol for the prevention of acute renal failure after renal cadaveric transplantation.Transplantation1987; 44: 784–88.
32.
TiggelerR.G., BerdenJ.H., HoitsmaA.J., KoeneR.A.. Prevention of acute tubular necrosis in cadaveric kidney transplantation by the combined use of mannitol and moderate hydration.Ann Surg1985; 201: 246–51.
33.
PorrasI., Gonzalez-PosadaJ.M., LosadaM.. A multivariate analysis of the risk factors for posttransplant renal failure: beneficial effect of a flush solution with mannitol.Transplant Proc1992; 24: 52–53.
GrinoJ.M., MiravitllesR., CastelaoA.M.. Flush solution with mannitol in the prevention of post-transplant renal failure.Transplant Proc1987; 19: 4140–2.
36.
HoitsmaA.J., GroenewoudA.F., BerdenJ.H., van LierH.J., KoeneR.A.. Important role for mannitol in the prevention of acute renal failure after cadaveric kidney transplantation.Transplant Proc1987; 19(1 Pt 3): 2063–64.
37.
LauzuricaR., TeixidoJ., SerraA.. Hydration and mannitol reduce the need for dialysis in cadaveric kidney transplant recipients treated with CyA.Transplant Proc1992; 24: 46–7.
38.
WeimarW., GeerlingsW., BijnenA.B.. A controlled study on the effect of mannitol on immediate renal function after cadaver donor kidney transplantation.Transplantation1983; 35: 99–101.
39.
SolomonR., WernerC., MannD., D'EliaJ., SilvaP.. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents.N Engl J Med1994; 331: 1416–20.
40.
StevensM.A., McCulloughP.A., TobinK.J.. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation.J Am Coll Cardiol1999; 33: 403–11.
41.
AntoH.R., ChouS.Y., PorushJ.G., ShapiroW.B.. Infusion intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency.Arch Intern Med1981; 141: 1652–6.
42.
WeisbergL.S., KurnikP.B., KurnikB.R.. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus.Kidney Int1994; 45: 259–65.
MalinoskiD.J., SlaterM.S., MullinsR.J.. Crush injury and rhabdomyolysis.Crit Care Clin2004; 20: 171–92.
45.
JohnstonP.A., BernardD.B., PerrinN.S., LevinskyN.G.. Prostaglandins mediate the vasodilatory effect of mannitol in the hypoperfused rat kidney.J Clin Invest1981; 68: 127–33.
46.
TayM., ComperW.D., VassiliouP., GlasgowE.F., BakerM.S., PrattL.. The inhibitory action of oxygen radical scavengers on proteinuria and glomerular heparan sulphate loss in the isolated perfused kidney.Biochem Int1990; 20: 767–78.
47.
BratellS., FolmerzP., HanssonR.. Effects of oxygen free radical scavengers, xanthine oxidase inhibition and calcium entry-blockers on leakage of albumin after ischaemia. An experimental study in rabbit kidneys.Acta Physiol Scand1988; 134: 35–41.
48.
FinferS., BellomoR., BoyceN., FrenchJ., MyburghJ., NortonR.. A comparison of albumin and saline for fluid resuscitation in the intensive care unit.N Engl J Med2004; 350: 2247–56.
49.
SchortgenF., LacheradeJ.C., BruneelF.. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study.Lancet2001; 357: 911–6.
50.
CittanovaM.L., LeblancI., LegendreC., MouquetC., RiouB., CoriatP.. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients.Lancet1996; 348: 1620–2.
BoldtJ., PriebeH.J.. Intravascular volume replacement therapy with synthetic colloids: is there an influence on renal function?Anesth Analg2003; 96: 376–82.
53.
RiouB., CittanovaM.L.. An international review of HES.Intensive Care Med1999; 25: 1340–1.
54.
LegendreC., ThervetE., PageB., PercheronA., NoelL.H., KreisH.. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation.Lancet1993; 342: 248–9.
55.
VogtN.H., BothnerU., LerchG., LindnerK.H., GeorgieffM.. Large-dose administration of 6% hydroxyethyl starch 200/0.5 total hip arthroplasty: plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin.Anesth Analg1995; 83: 262–8.
56.
JungheinrichC., SauermannW., BepperlingF., VogtN.H.. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopaedic surgery: a randomised, double-blind study.Drugs2004; 5: 1–9.
57.
YounesR.N., YinK.C., AminoC.J., ItinosheM., Rocha e SilvaM., BiroliniD.. Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room.World J Surg1998; 22: 2–5.
58.
BoldtJ., MuellerM., MengesT., PapsdorfM., HempelmannG.. Influence of different volume therapy regimens on regulators of the circulation in the critically ill.Br J Anaesth1996; 77: 480–7.
59.
LangK., BoldtJ., SuttnerS., HaischG.. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery.Anesth Analg2001; 93: 405–9.
60.
WilkesN.J., WoolfR., MutchM.. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients.Anesth Analg2001; 93: 811–6.
61.
GanT.J., Bennett-GuerreroE., Phillips-ButeB.. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Hextend Study Group.Anesth Analg1999; 88: 992–8.
62.
WiesenP., CanivetJ.L., LedouxD., RoedigerL., DamasP.. Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study.Acta Anaesthesiol Belg2005; 56: 257–63.
63.
KellumJ.A.. Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline.Crit Care Med2002; 30: 300–5.
64.
RobertsI., AldersonP., BunnF., ChinnockP., KerK., SchierhoutG.. Colloids versus crystalloids for fluid resuscitation in critically ill patients.Cochrane Database Syst Rev2004; (4): CD000567.
65.
GinesP., TitoL., ArroyoV.. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.Gastroenterology1988; 94: 1493–502.
66.
SortP., NavasaM., ArroyoV.. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.N Engl J Med1999; 341: 403–9.
67.
LucaA., Garcia-PaganJ.C., BoschJ.. Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis.Hepatology1995; 22: 753–8.
68.
GinesA., Fernandez-EsparrachG., MonescilloA.. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.Gastroenterology1996; 111: 1002–10.
69.
PozziM., OsculatiG., BoariG.. Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites.Gastroenterology1994; 106: 709–19.
70.
CabreraJ., IngladaL., QuinteroE.. Large-volume paracentesis and intravenous saline: effects on the renin-angiotensin system.Hepatology1991; 14: 1025–28.
71.
PintoP.C., AmerianJ., ReynoldsT.B.. Large-volume paracentesis in nonedematous patients with tense ascites: its effect on intravascular volume.Hepatology1988; 8: 207–10.
72.
KaoH.W., RakovN.E., SavageE., ReynoldsT.B.. The effect of large volume paracentesis on plasma volume-a cause of hypovolemia?Hepatology1985; 5: 403–7.
73.
FernandezJ., MonteagudoJ., BargalloX.. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis.Hepatology2005; 42: 627–34.
74.
FassioE., TergR., LandeiraG.. Paracentesis with Dextran 70 vs. paracentesis with albumin in cirrhosis with tense ascites. Results of a randomized study.J Hepatol1991; 14: 310–6.
75.
SalernoF., BadalamentiS., LorenzanoE., MoserP., IncertiP.. Randomized comparative study of hemaccel vs. albumin infusion after total paracentesis in cirrhotic patients with refractory ascites.Hepatology1991; 13: 707–13.
76.
AltmanC., BernardB., RoulotD., VitteR.L., InkO.. Randomized comparative multicenter study of hydroxyethyl starch versus albumin as a plasma expander in cirrhotic patients with tense ascites treated with paracentesis.Eur J Gastroenterol Hepatol1998; 10: 5–10.
77.
DawidsonI.J., SandorZ.F., CoorpenderL.. Intraoperative albumin administration affects the outcome of cadaver renal transplantation.Transplantation1998; 53: 774–82.
78.
DawidsonI., CoorpenderL., DrakeD.. Intraoperative albumin improves the outcome of cadaver renal transplantation.Transplant Proc1987; 19: 4137–9.
79.
DawidsonI., PetersP., SagalowskyA., AbshierD., CoorpenderL.. The effect of intraoperative fluid management on the incidence of acute tubular necrosis.Transplant Proc1987; 19: 2056–7.
80.
DawidsonI., BerglinE., BryngerH., ReischJ.. Intravascular volumes and colloid dynamics in relation to fluid management in living related kidney donors and recipients.Crit Care Med1987; 15: 631–6.
81.
CinatM.E., WallaceW.C., NastanskiF.. Improved survival following massive transfusion in patients who have undergone trauma.Arch Surg1999; 134: 964–70.
82.
RaoT.L., MathruM., SalemM.R., El-EtrA.A.. Serum potassium levels following transfusion of frozen erythrocytes.Anesthesiology1980; 52: 170–2.
83.
PerkinsR.M., AboudaraM.C., AbbottK.C., HolcombJ.B.. Resuscitative Hyperkalemia in Noncrush Trauma: A Prospective, Observational Study.Clin J Am Soc Nephrol2007; 2: 313–9.
84.
BansalI., CalhounB.W., JosephC., PothiawalaM., BaronB.W.. A comparative study of reducing the extracellular potassium concentration in red blood cells by washing and by reduction of additive solution.Transfusion2007; 47: 248–50.
85.
FitzpatrickC.M., SavageS.A., KerbyJ.D., ClouseW.D., KashyapV.S.. Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage.J Am Coll Surg2004; 199: 693–701.
86.
GurneyJ., PhilbinN., RiceJ.. A hemoglobin based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus Hetastarch (HEX) in an uncontrolled liver injury hemorrhagic shock swine model with delayed evacuation.J Trauma2004; 57: 726–38.
87.
FitzpatrickC.M., BiggsK.L., AtkinsB.Z.. Prolonged low-volume resuscitation with HBOC-201 in a large-animal survival model of controlled hemorrhage.J Trauma2005; 59: 273–81.
88.
JohnsonT., ArnaudF., DongF.. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation - effects on histopathology and organ function.Crit Care Med2006; 34: 1464–74.
89.
SprungJ., KindscherJ.D., WahrJ.A.. The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized, single-blinded trial.Anesth Analg2002; 94: 799–808.
90.
GonzalezP., HackneyA.C., JonesS.. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study.J Investig Med1997; 45: 258–64.
91.
KasperS.M., WalterM., GruneF., BischoffA., ErasmiH., BuzelloW.. Effects of a hemoglobin-based oxygen carrier (HBOC-201) on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery.Anesth Analg1996; 83: 921–7.
92.
JohnsonJ.L., MooreE.E., OffnerP.J.. Resuscitation with a blood substitute abrogates pathologic postinjury neutrophil cytotoxic function.J Trauma2001; 50: 449–56.
93.
GouldS.A., MooreE.E., HoytD.B.. The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery.J Am Coll Surg1998; 187: 113–20.
94.
SchortgenF., SoubrierN., DelclauxC.. Hemodynamic tolerance of intermittent hemodialysis in critically ill patients: usefulness of practice guidelines.Am J Respir Crit Care Med2000; 162: 197–202.
95.
PaganiniE.P., SandyD., MorenoL., KozlowskiL., SakaiK.. The effect of sodium and ultrafiltration modelling on plasma volume changes and haemodynamic stability in intensive care patients receiving haemodialysis for acute renal failure: a prospective, stratified, randomized, cross-over study.Nephrol Dial Transplant1996; 11(Suppl 8): S32–7.
96.
LeblancM., MorenoL., RobinsonO.P., TapolyaiM., PaganiniE.P.. Bicarbonate dialysate for continuous renal replacement therapy in intensive care unit patients with acute renal failure.Am J Kidney Dis1995; 26: 910–7.
97.
DavenportA.. Audit of the effect of dialysate sodium concentration on inter-dialytic weight gains and blood pressure control in chronic haemodialysis patients.Nephron Clin Pract2006; 104: c120–5.
98.
Di FilippoS., ManzoniC., AndrulliS., TentoriF., LocatelliF.. Sodium removal during pre-dilution haemofiltration.Nephrol Dial Transplant2003; Aug; 18 (Suppl 7): S31–6.
99.
UchinoS., ColeL., MorimatsuH., GoldsmithD., RoncoC., BellomoR.. Solute mass balance during isovolaemic high volume haemofiltration.Intensive Care Med2003; 29: 1541–6.
DellingerR.P., CarletJ.M., MasurH.. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.Intensive Care Med2004; 30: 536–55.
105.
StoryD.A., RoncoC., BellomoR.. Trace element and vitamin concentrations and losses in critically ill patients treated with continuous venovenous hemofiltration.Crit Care Med1999; 27: 220–3.
106.
LafranceJ.P., LeblancM.. Metabolic, electrolytes, and nutritional concerns in critical illness.Crit Care Clin2005; 21: 305–27.
107.
TroyanovS., GeadahD., GhannoumM., CardinalJ., LeblancM.. Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy.Intensive Care Med2004; 30: 1662–5.
108.
ThomasA.N., GuyJ.M., KishenR., GeraghtyI.F., BowlesB.J., VadgamaP.. Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients.Nephrol Dial Transplant1997; 12: 1212–7.
109.
KierdorfH., LeueC., HeintzB., RiehlJ., MelzerH., SieberthH.G.. Continuous venovenous hemofiltration in acute renal failure: is a bicarbonate- or lactate-buffered substitution better?Contrib Nephrol1995; 116: 38–47.
110.
MorgeraS., HeeringP., SzentandrasiT.. Comparison of a lactate-versus acetate-based hemofiltration replacement fluid in patients with acute renal failure.Ren Fail1997; 19: 155–64.
111.
HeeringP., IvensK., ThumerO., BrauseM., GrabenseeB.. Acid-base balance and substitution fluid during continuous hemofiltration.Kidney Int Suppl1999; 72: S37–40.
112.
ZimmermanD., CotmanP., TingR., KaranicolasS., TobeS.W.. Continuous veno-venous haemodialysis with a novel bicarbonate dialysis solution: prospective cross-over comparison with a lactate buffered solution.Nephrol Dial Transplant1999; 14: 2387–91.
113.
McLeanA.G., DavenportA., CoxD., SwenyP.. Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction.Kidney Int2000; 58: 1765–72.
114.
BarenbrockM., HausbergM., MatzkiesF., de la MotteS., SchaeferR.M.. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients.Kidney Int2000; 58: 1751–7.
115.
VeechR.L.. The untoward effects of the anions of dialysis fluids.Kidney Int1988; 34: 587–97.
116.
JohnstonR.V., BoiteauP., CharleboisK., LongS., and DavidU.. Responding to tragic error: lessons from Foothills Medical Centre.CMAJ2004; 170: 1659–60.
117.
CulleyC.M., BernardoJ.F., GrossP.R.. Implementing a standardized safety procedure for continuous renal replacement therapy solutions.Am J Health Syst Pharm2006; 63: 756–63.
118.
BarlettaJ.F., BarlettaG.M., BrophyP.D., MaxvoldN.J., HackbarthR.M., BunchmanT.E.. Medication errors and patient complications with continuous renal replacement therapy.Pediatr Nephrol2006; 21: 842–5.
